Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.6 USD 8.11% Market Closed
Market Cap: 279.9m USD
Have any thoughts about
Lifecore Biomedical Inc?
Write Note

Net Margin
Lifecore Biomedical Inc

5.1%
Current
-55%
Average
3.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.1%
=
Net Income
6.5m
/
Revenue
128.4m

Net Margin Across Competitors

Country US
Market Cap 279.9m USD
Net Margin
5%
Country JP
Market Cap 53.2T JPY
Net Margin
4%
Country CH
Market Cap 190.5B CHF
Net Margin
12%
Country US
Market Cap 80.2B USD
Net Margin
11%
Country ZA
Market Cap 45.5B Zac
Net Margin
8%
Country FR
Market Cap 41.2B EUR
Net Margin
4%
Country MY
Market Cap 167.6B MYR
Net Margin
4%
Country US
Market Cap 37B USD
Net Margin
5%
Country ZA
Market Cap 35.9B Zac
Net Margin
14%
Country CN
Market Cap 258.3B CNY
Net Margin
23%
Country US
Market Cap 35.2B USD
Net Margin
13%
No Stocks Found

Lifecore Biomedical Inc
Glance View

Market Cap
279.9m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.95 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.1%
=
Net Income
6.5m
/
Revenue
128.4m
What is the Net Margin of Lifecore Biomedical Inc?

Based on Lifecore Biomedical Inc's most recent financial statements, the company has Net Margin of 5.1%.